General Characteristics and Mechanism of Action
The triazole class includes medications such as itraconazole, fluconazole, voriconazole, terconazole, posaconazole, and ravuconazole (currently in clinical trials). The primary difference between triazoles and older imidazoles is their significantly higher selectivity for fungal 14$\alpha$-demethylase.
Due to this specificity, triazoles virtually do not affect the human enzyme 17,20-desmolase, avoiding disruptions in sex hormone and glucocorticoid synthesis.
Itraconazole and Fluconazole: Clinical Applications
Itraconazole successfully replaces ketoconazole in the treatment of systemic mycoses and dermatophytoses. Its absorption depends directly on gastric acidity: capsules should be taken with a heavy meal, while the oral solution should be taken on an empty stomach. The drug actively accumulates in the skin and nails but exhibits poor penetration into biological fluids.
Fluconazole is the most widely used antifungal agent, with a bioavailability of approximately 100%. Unlike itraconazole, its absorption is independent of gastric pH, and the drug readily penetrates all body compartments, including the cerebrospinal fluid (CSF). This makes it the drug of choice for systemic candidiasis and cryptococcal meningitis.
Voriconazole and Posaconazole
Voriconazole possesses one of the broadest spectra of activity among oral agents and serves as the drug of choice for invasive aspergillosis and infections caused by Fusarium and Scedosporium species. A notable feature of the intravenous formulation of voriconazole is the inclusion of the excipient sulfobutylether beta-cyclodextrin sodium, which is why it is not recommended in patients with renal impairment.
Posaconazole exhibits potent fungicidal activity and is used for the prophylaxis of candidiasis and aspergillosis in patients over 13 years of age with prolonged neutropenia or severe graft-versus-host disease.
Safety and Drug Interactions
Triazole therapy requires careful medical monitoring due to significant pharmacokinetic interactions and adverse effects:
- Metabolism: These drugs heavily impact the cytochrome P450 system, increasing the plasma concentrations of medications such as warfarin, phenytoin, and cyclosporine.
- Inducers: Rifampin, ritonavir, and barbiturates can decrease blood concentrations of antifungal agents.
- Adverse Reactions: Hepatotoxicity, gastrointestinal upset, alopecia with prolonged courses, and severe conditions such as Stevens-Johnson syndrome may occur.